Formula-to-Syndrome Effect and Pharmacomicrobiomics Mechanism of Colon Delivery of Baitouweng Decoction for Treating Large Intestine Damp-heat Syndrome of Ulcerative Colitis

Status: Recruiting
Location: See location...
Intervention Type: Drug, Other
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

Baitouweng Decoction is traditionally used to treat large intestine damp-heat syndrome of ulcerative colitis (UC) by oral administration and rectal enema.The project applicant's invention of transendoscopic entral tubing (TET) has been used in Baitouweng Decoction for the treatment of UC across the whole colon, however, the efficacy have not been reported and the underlying mechanism is still unclear. Compared with oral and rectal enema, Baitouweng Decoction by colon TET can improve the therapeutic effect by increasing the concentration of drugs in the whole colon, which need to be verified. This project will reveal the prescription effect and drug-microbiome interaction mechanism of whole colon repeated administration of Baitouweng Decoction in the treatment of UC through clinical randomized controlled studies, deep intestinal dynamic sampling, integrated analysis of multi-omics and TCM prescription metabolomics studies, and provide key scientific basis for the establishment of a new approach of whole colon repeated administration of TCM and a new strategy for the treatment of UC.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:

• Patients diagnosed with ulcerative colitis;

• The patients are in mild to moderate active stage with Mayo score of 3-8.

• Patients with damp-heat syndrome of large intestine according to TCM syndrome differentiation: according to the expert consensus on integrated traditional Chinese and Western medicine diagnosis and treatment of UC, the main symptoms are diarrhea, mucopurulent and bloody stool, abdominal pain, and tenesmus. Secondary symptoms: anal burning, body heat is not Yang, dry mouth and bitter mouth, short red urine. Tongue pulse: tongue red fur yellow greasy, pulse slippery number. The determination of the above 8 syndromes can be made if there are 2 main symptoms and 1-2 secondary symptoms. The tongue pulse is for reference only.

• The patients who can tolerate Baitouweng Decoction;

• The patients who tolerance to colonoscopy and TET;

• The patients who know and agree to participate in the clinical trial.

Locations
Other Locations
China
Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
RECRUITING
Nanjing
Contact Information
Primary
Faming Zhang, PhD
fzhang@njmu.edu.cn
02558509670
Backup
Bota Cui
cuibota@njmu.edu.cn
02558509883
Time Frame
Start Date: 2024-05
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 144
Treatments
Experimental: Colonic TET treatment group
Baitouweng Decoction is administered through the colonic TET.
Placebo_comparator: Colonic TET placebo group
The same volume of placebo as the colonic TET treatment group was administered through the colonic TET.
Active_comparator: Rectal enema group
Baitouweng Decoction is administered through rectal enema.
Active_comparator: Oral group
Baitouweng Decoction is administered through oral.
Sponsors
Collaborators: Heilongjiang University of Chinese Medicine
Leads: The Second Hospital of Nanjing Medical University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials